MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$80,547,000
(-184.89%↓ Y/Y)
Net loss
-$79,241,000
(-203.20%↓ Y/Y)
Other comprehensive
(gain) income
-$1,306,000
(38.91%↑ Y/Y)
Loss before income
taxes
-$78,391,000
(-216.88%↓ Y/Y)
Income tax expense
$850,000
(-39.16%↓ Y/Y)
Foreign currency
translation adjustment
-$580,000
(-190.20%↓ Y/Y)
Unrealized (loss) gain on
available for sale...
-$483,000
Reclassification adjustment for
realized net (loss) gain...
$243,000
Interest and investment
income
$5,138,000
(-34.88%↓ Y/Y)
Loss from operations
-$79,773,000
(-159.20%↓ Y/Y)
Interest expense
$2,731,000
(-5.07%↓ Y/Y)
Other non-operating
income (expense), net
-$1,025,000
(-199.90%↓ Y/Y)
Research and development
$59,891,000
(79.08%↑ Y/Y)
General and
administrative
$19,882,000
(61.20%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc (CNTA)